Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Novel neuroprotective strategies in glaucoma therapeutics - Part II

May 10, 2006

New intraocular delivery system of antiproliferative agents reported

May 10, 2006

A novel multitargeted tyrosine kinase prodrug proves beneficial for CNV disorders

May 10, 2006

Opticin may contribute to the antiangiogenic properties of the vitreous humor

May 10, 2006

Novel neuroprotective strategies in glaucoma therapeutics - Part I

May 9, 2006

Snapshots on novel therapeutic strategies for choroidal neovascularization

May 8, 2006

Geranylgeranyltransferase type I, a potential therapeutic target in glaucoma

May 8, 2006

The marine product misakinolide A could be useful in glaucoma therapy

May 8, 2006

Preclinical data on antioxidant drugs for AMD reported by Othera

May 5, 2006

Small alpha5beta1 integrin inhibitor reduces choroidal neovascularization in different animal models

May 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...